Wound Care Plus, LLC Adopts the MolecuLight i:X® as a Standard Point-of-Care Device for its Wound Care Service Offering to the Long-Term Care and Extended Care Markets

December 10, 2020 -MolecuLight i:X will Provide Essential Real-Time Information to Assist Wound Care Plus’s Advanced Wound Care Consultants in Providing the Highest Quality Wound Care

Toronto, Canada and Midwest, USA – (December 10, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing bacteria, announced that Wound

… Read More

Results Published from 2-Year Study of 229 Wounds Treated in an NHS Clinic Show Fluorescence Point-of-Care Imaging Improved Wound Healing Rates by 23%

November 25, 2020 -Study also Reveals that Routine Use of Fluorescence Imaging Along with Clinical Assessment Resulted in Significant Reductions in Antibiotic Usage and Antimicrobial Dressing Costs

Toronto, Canada and London, UK – (November 25, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing bacteria, announced the

… Read More

Results from 350-Patient FLAAG Trial Show MolecuLight Point-of-Care Imaging Improves Detection of High Bacterial Burden in Wounds Four-fold over Standard of Care Assessment

September 29, 2020 -Study also Demonstrates that MolecuLight Fluorescence Imaging of Bacteria at Point-of-Care Resulted in Changes to Treatment Planning in 69% of All Patient Cases

Toronto, CANADA – (September 29, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announced publication of results from the

… Read More

MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X® Procedure for Bacterial Imaging using Fluorescence

June 11, 2020 -New Code Enables Facility Reimbursement to Hospital Outpatient Centers Performing MolecuLight’s Procedure Benefiting Wound Care Patients

Toronto, CANADA – (June 11, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces that the Centers for Medicare & Medicaid Services (CMS) has

… Read More

MolecuLight Announces Industry Partnership and Virtual Exhibit of its MolecuLight i:X® Platform at WoundCon™ 2020, the Largest Conference for Wound Care

April 1, 2020 -Novel Virtual Conference Attracts 10,000 Wound Care Professionals as Alternate to Live Medical Conferences Given Travel Challenges Due to Covid-19

Toronto, CANADA and Atlantic Beach, USA – (April 1, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces its Sponsorship and participation

… Read More

First Published Study to Report In Vitro Detection of Fluorescence from Bacteria in Biofilm with Point-of-care Wound Imaging Device

March 3, 2020 -In Vitro Study Demonstrates Detectable Red Fluorescence from 88% of Planktonic and Biofilm Wound Pathogens when Imaged by the MolecuLight i:X® Imaging Device

Toronto, CANADA – (March 3, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announces the publication of  “… Read More